SCHOFIELD, Wis., Dec. 1, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic(TM), announced today that it has recently secured funding through a private placement in the amount of $500,000, the largest amount to date, which will allow the Company to initiate further efforts to reach its goals and objectives as outlined in its business plan.
This funding has enabled PuraMed BioScience to purchase air time for the Company's first direct response television commercial, expected to begin airing within the coming weeks in select test markets. The funding will also be allocated for several business activities that will further demonstrate the effectiveness and marketability of the LipiGesic(TM) series of products.
"We are pleased to have secured the highest level of funding to date in order to continue our efforts in launching our first product, LipiGesic M, on a national level," said PuraMed BioScience CEO Russell Mitchell. "Airing our direct response commercial in test markets is the first step in introducing the LipiGesic(TM) brand to consumers. This is one component of our overall plan to make LipiGesic(TM) the most well-known and trusted brand for non-prescription medications for migraine headaches and other illnesses; we look forward to continuing our work to achieve that goal."
About the Company:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic(TM) M, which provides acute relief from migraine headaches; the Company also has plans to launch LipiGesic(TM) PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic(TM) H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company's group page on Facebook by searching "PuraMed BioScience" and follow the Company on Twitter at www.twitter.com/puramed.
Forward Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.